Frank Pasqualone

Frank Pasqualone, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Enveric Biosciences, Inc. and Theravance Biopharma, Inc. Over a trading history stretching from 20 May 2021 to 23 December 2025, the count stands at 6 filings.

Every open-market trade on record is a purchase: 1 purchase worth €2,012, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 share grants.

On 30 December 2025 came the latest disclosure, a share grant in Enveric Biosciences, Inc. The last insider purchase was made public on 19 September 2023, 1,125 days ago. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.